Author:
Tylutki Zofia,Polak Sebastian,Wiśniowska Barbara
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,Genetics,Biochemistry
Reference60 articles.
1. Sorger PK, Allerheiligen SRB, Abernethy DR, Altman RB, Brouwer KLR, Califano A, et al. Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms. An NIH white Pap. by QSP Work. Gr. NIH Bethesda; 2011. p. 1–48.
2. Huang S-M, Abernethy DR, Wang Y, Zhao P, Zineh I. The utility of modeling and simulation in drug development and regulatory review. J Pharm Sci. 2013;102:2912–23.
3. Lee JY, Garnett CE, Gobburu JVS, Bhattaram VA, Brar S, Earp JC, et al. Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008. Clin Pharmacokinet. 2011;50:627–35.
4. . Jefferys D, Gennery BA, Manos S, Baxter G, Page C, Horton J. Virtual R & D Which path will you take ? Pharma 2020. 2007;1–22.
5. Stockbridge N, Morganroth J, Shah RR, Garnett C. Dealing with global safety issues : was the response to QT-liability of non-cardiac drugs well coordinated? Drug Saf. Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD, USA.; 2013;36:167–82. Seeding publication for the currently discussed drug cardiac safety paradigm shift.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献